ACRIXOLIMAB
UNII KHG83J8RMW

Substance Identification & Data

This profile provides standardized clinical and technical data for Acrixolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KHG83J8RMW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2506324-29-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KHG83J8RMW

CAS Registry Number

2506324-29-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ACRIXOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188591

National Cancer Institute reference terminology for clinical and research data.

INN ID

11969

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Acrixolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ACRIXOLIMAB

Common Names & Synonyms

ACRIXOLIMAB [INN]

IMMUNOGLOBULIN G4 (222-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN MONOCLONAL YBL-006 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL YBL-006 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-441) (VH (HOMO SAPIENS IGHV3-30*01 (95.8%)-(IGHD)- IGHJ5*01 (100%), CDR-IMGT (8.8.7) (26-33.51-58.97- 103)) (1-114)-HOMO SAPIENS IGHG4*01, G4V5 H P10 (CH1 (115-212), HINGE 1-12 S10>P (222) (213-224), CH2 (225-334), CH3 (335-439), CHS (440-441)) (115- 441)), (128-220')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-220') (V-KAPPA (HOMO SAPIENS IGKV2- 40*01 (94.1%)-IGKJ3*01 (91.7%) P120>Q (106), CDR-IMGT (12.3.9) (27-38.56-58.95-103)) (1'-113')- HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159), V101 (197) (114'-220')); DIMER (220-220'':223-223'')- BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

External Clinical & Regulatory Resources

Previous UNIIKHF84EFW5M

Next UNIIKHH5YE32CG